New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
D000328:Adult; D000368:Aged; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D002860:Chromium Radioisotopes; D004359:Drug Therapy, Combination; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006041:Goats / Q000276:immunology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008858:Microscopy, Phase-Contrast; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use; D012910:Snake Venoms; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*
D002860:Chromium Radioisotopes; D005343:Fibrinolytic Agents; D012910:Snake Venoms; D005340:Fibrinogen; D006493:Heparin; D010447:Peptide Hydrolases; D013300:Streptokinase